imvaria is a health tech company developing digital biomarkers in serious and/or rare diseases, founded by a team of former dual-trained Stanford + Google physician/engineers. We target better disease stratification to drive success in future trials. The Company’s lead asset has been assigned FDA’s Breakthrough Designation, and the team is developing a growing pipeline of tools across a variety of disease areas and data types.

Visit website

Buttontwitter Buttonlinkedin

Partners & Attendees

Acc1.001
Mit tech review.001
Nvidia.001
Svb.001
Facebook.001
Forbes.001
Applause .001
Twentybn.001
Sama21.001
Intel21.001
Rasalogo.001
Graphcoreai.001
This website uses cookies to ensure you get the best experience. Learn more